Orexigen Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Orexigen Therapeutics generated cash of -$109,713,000, which is less than the previous year. Cash used in financing activities reached the amount of $154,557,000 last year. Net change in cash is therefore -$62,928,000.
Cash Flow
| 2013 | -70.81M | -21.27M | 111.88M |
|---|---|---|---|
| 2014 | 26.82M | -23.44M | 2.73M |
| 2015 | -54.47M | 41.42M | 64.25M |
| 2016 | -109.71M | -107.05M | 154.55M |
OREX Cash Flow Statement (2013 – 2016)
| 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|
Cash at beginning of period | 155.42M | 104.24M | 98.12M | 78.33M |
Operating activities | ||||
Net income | -24.52M | -68.68M | -37.52M | -77.67M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 3.98M | 1.03M | 933K | 912K |
Stock-based compensation expense | 10.33M | 15.22M | 15.29M | 11.56M |
| Deferred income tax benefit | 10.33M | 15.22M | 15.29M | 11.56M |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 5.66M | -4.25M | -2.49M | 0 |
Inventories | 1.45M | -9.61M | -1.19M | 0 |
Accounts payable | 11.81M | 1.02M | 2.10M | -2.29M |
Cash generated by operating activities | -109.71M | -54.47M | 26.82M | -70.81M |
Investing activities | ||||
Purchases Of Investments | -23.59M | -119.59M | -130.39M | -85.64M |
Investments In Property Plant And Equipment | -330K | -538K | -246K | -640K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -107.05M | 41.42M | -23.44M | -21.27M |
Financing activities | ||||
Common Stock Issued | 188K | 4.45M | 2.73M | 1.33M |
Payments for dividends | -19.94M | -56K | 0 | 0 |
Repurchases of common stock | -92.49M | -155.42M | -104.24M | -98.12M |
Repayments of term debt | -9.97M | 0 | 0 | 0 |
Cash used in financing activities | 154.55M | 64.25M | 2.73M | 111.88M |
Net Change In Cash | -62.92M | 51.17M | 6.12M | 19.78M |
Cash at end of period | 92.49M | 155.42M | 104.24M | 98.12M |
| Data source | Data source | Data source | Data source |